Aquestive Therapeutics Inc (AQST) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Legal ... [Yahoo! Finance]
Aquestive Therapeutics, Inc. (AQST)
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aquestive.com/investor-relations
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Total Revenue (Q4 2025): $13 million, a 10% increase from $11.9 million in Q4 2024. Manufacturing and Supply Revenue (Q4 2025): $12 million, up from $10.7 million in Q4 2024. Total Revenue (Full Year 2025): $44.5 million, down from $57.6 million in 2024. Manufacturing and Supply Revenue (Full Year 2025): $40.2 million, slightly up from $40 million in 2024. R&D Expenses (Q4 2025): $3.2 million, down from $4.9 million in Q4 2024. R&D Expenses (Full Year 2025): $17.2 million, down from $20.3 million in 2024. SG&A Expenses (Q4 2025): $32.8 million, up from $16 million in Q4 2024, including one-time legal expenses. SG&A Expenses (Full Year 2025): $79.8 million, up from $50.2 million in 2024, including one-time legal expenses. Net Loss (Q4 2025): $31.9 million, or $0.26 per share, including one-time legal expenses. Net Loss (Full Year 2025): $83.8 million, or $0.78 per share, including one-time legal expenses. Non-GAAP Adjusted
Show less
Read more
Impact Snapshot
Event Time:
AQST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AQST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AQST alerts
High impacting Aquestive Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AQST
News
- Investor Notice: Robbins LLP Informs Investors of the Aquestive Therapeutics, Inc. Class Action LawsuitBusiness Wire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Aquestive Therapeutics, Inc. Securities and Sets a Lead Plaintiff Deadline of May 4, 2026GlobeNewswire
- INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive TherapeuticsPR Newswire
- Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateGlobeNewswire
AQST
Earnings
- 3/4/26 - Miss
AQST
Sec Filings
- 3/4/26 - Form S-8
- 3/4/26 - Form 10-K
- 3/4/26 - Form 8-K
- AQST's page on the SEC website